In conclusion, the present study demonstrated that Lobetyolin exhibited anti‐cancer effect on colon cancer HCT‐116 cells through the apoptosis regulated by ASCT2‐modulated glutamine metabolism, which was governed by p53. Here, SLC1A5 is linked to cancer.